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 1 
INTRODUCTION 
 
Healthcare-associated infections are an increasingly recognized 
problem. The emergence of healthcare-associated infections caused 
by multidrug-resistant microorganisms is of increasing concern as 
well.  
The author initiated, conducted, or participated in the presented 
studies and examined the antimicrobial resistance and/or the 
molecular epidemiology of drug-resistant pathogens of healthcare-
associated infections.  
The objectives, the methods, the results, and the conclusions of the 
following studies performed on important drug-resistant healthcare-
associated pathogens (such as penicillin-nonsusceptible 
Streptococcus pneumoniae, vancomycin-resistant Enterococcus spp., 
multidrug-resistant Enterobacter spp. and Acinetobacter spp.) are 
outlined briefly in this thesis book. 
 
 
 
 
 
 
 
 
 
 2 
OBJECTIVES 
 
1. The aim of the study was the examination of antimicrobial 
susceptibility of clinical S. pneumoniae isolates collected in 
Hungary in 2000. A further aim of the study was to examine 
the correlations between the MICs of penicillin-cefotaxime, 
penicillin-levofloxacin, and cefotaxime-levofloxacin; 
 
2. the aim of the study was to collect and characterize 
vancomycin resistant Enterococcus faecium (VREF) clinical 
isolates from Hungary and Serbia and to examine the 
genetic relationship between the collected isolates and the 
previously identified international high-risk Enterococcal 
Clonal Complex, the Enterococcus faecium clonal–complex, 
CC-17; 
 
3. the aim of our study was to help a Hungarian hospital trying 
to stop an outbreak caused by multidrug-resistant A. 
baumannii; 
 
4. the aim of the study was to investigate the molecular 
epidemiological background of the high occurrence of 
multidrug-resistant E. cloacae isolates in a Hungarian 
perinatal intensive care unit in a one-year-long period; 
 
5. the aim of our study was the examination of the molecular 
epidemiology of confirmed ESBL isolates sent in a three-
year-long period (2002-2004) for ESBL confirmation to the 
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National Center for Epidemiology in the national ESBL 
surveillance from 25 healthcare facilities throughout the 
country. The outbreak strain isolated from the first reported 
outbreak caused by ESBL E. cloacae in Hungary was 
further examined to characterize the resistance determinants 
of the ESBL plasmid; 
 
6. molecular epidemiology, cyclohexane tolerance, and Phe-
Arg-ß-naphtylamide (PAβN) susceptibility of multidrug-
resistant E. cloacae isolates with third-generation 
cephalosporin and high-level fluoroquinolone resistance 
collected in Hungarian health-care facilities in a nationwide 
survey are reported in the last presented study. 
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MATERIALS AND METHODS 
 
1. Penicillin susceptibility of 327 Streptococcus pneumoniae 
strains isolated from clinical specimens between January 
and June 2000 was determined by 1 μg oxacillin discs. Two 
hundred and seven strains (63.3%) were proved to be 
penicillin-susceptible (PS). Minimal inhibitory 
concentrations for penicillin of the remaining 120 strains 
(36.7%) were measured by the E-test method. Further 19 
strains belonged to PS category, while 71 strains (22.3%) 
exhibited intermediate penicillin susceptibility (IPS) and 30 
strains (8.9%) proved to be penicillin-resistant (PR). IPS 
and PR strains were examined further by cefotaxime and 
levofloxacin E-test. 
  
2. Identification at species level and detection of van genes 
were performed by PCR on all the isolates (n=65). VREF 
isolates (n=36) were initially typed by PFGE, followed by 
multiple locus variable-number tandem repeat analysis 
(MLVA) and MLST performed on the vanB positive E. 
faecium outbreak strain. 
 
3.  Molecular epidemiological examinations were performed 
on 18 strains collected from 13 infected and two 
symptomless patients, and from the environment sampled in  
the hospital hygienic screening, performed investigating the 
small outbreak occurred in the particular unit in 2003.  As 
 5 
only a few data were available about the discriminatory 
power of the molecular epidemiological techniques for 
Hungarian A. baumanni strains, all the collected isolates 
have been examined not only with the gold standard 
technique (PFGE) but other frequently used techniques (AP-
PCR with ERIC-2 primers and RAPD with DAF-4 primer) 
as well. The class-1 integron patterns were also examined, 
as the collected strains were multidrug-resistant, and the 
presence of some class-1 integrons had been found 
previously by others to be connected with a high epidemic 
potential. 
 
4. All the isolates (n=142) have been examined by 
antimicrobial susceptibility testing and ERIC-PCR. 
Representative isolates (n=54 were further tested by PFGE. 
The seven ESBL positive isolates (derived from six 
patients) have been further tested by class-1-integron PCR 
and plasmid electrophoresis. 
 
5. ESBL confirmation was performed on all the isolates with 
double-disc test, ESBL E-test, and PCR based tests. 
Molecular epidemiological examinations were performed on 
the confirmed ESBL isolates with ERIC-2 primer. Isolates 
of the first outbreak were examined by plasmid 
electrophoresis, PFGE, PCR-sequencing, IEF, and, were 
drawn in conjugation experiments. Transconjugants were 
characterized by the same techniques and PREA. MIC 
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testing and specific PCR assays to detect transmissible 
resistance determinants were performed on the 
transconjugants and the parental strains simultaneously.  
 
6. A total of 113 multidrug-resistant E. cloacae isolates 
(recovered in 1997-2005) were subjected to disc diffusion 
tests, ERIC-PCR, and XbaI PFGE. Representatives of the 
ERIC-types were further tested (n=67) with cyclohexane 
and PAβN using ciprofloxacin as substrate. 
Chloramphenicol and tetracycline MICs of 39 isolates were 
also tested. 
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RESULTS 
  
1. Out of 68 IPS strains (the further three strains were died out 
during the study) 45, 21 and 2 were cefotaxime-susceptible, 
-intermediate and -resistant, respectively. Out of the 28 
surviving PR strains 2, 8 and 18 proved to be cefotaxime-
sensitive, -intermediate, and -resistant, respectively. Out of 
28 PR and 68 IPS strains isolated from respiratory tract 
samples 85 proved to be susceptible, 7 (7.2%) intermediate 
and 4 (4.1%) resistant to levofloxacin. All these four strains 
were isolated from inpatients of that particular clinic where 
levofloxacin has been administered since the autumn of 
1999. There was seen strong positive correlation between 
the MICs for penicillin and cefotaxime and week positive 
correlation between the MICs for levofloxacin and β-
lactams by rank order correlation analysis. 
  
2. Examining the macrorestriction profiles of the VanB VREF 
isolates recovered from blood, urine, and fecal cultures at a 
Budapest hospital between August 2003 and December 
2004, ≥ 87.5 % similarity was found calculating the Dice 
coefficient suggesting the monoclonal origin of isolates 
(type A). Type B strains were isolated from a small outbreak 
in Kistarcsa, Hungary; the type C strain was a sporadic 
isolate from a second hospital in Budapest. Examining the 
VanA VREF isolates from a Belgrade hospital in Serbia, an 
outbreak involving two clones affecting six departments was 
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identified by PFGE (types D and E). The vanA gene cluster 
of the type E clone was found transferable by in vitro 
conjugation experiments. The two vanA positive E. 
gallinarum blood culture isolates identified at the Belgrade 
hospital was also found epidemiologically related by PFGE. 
Molecular typing of the VanB E. faecium outbreak strain by 
MLVA and MLST revealed that the outbreak strain belongs 
to the CC-17 and the corresponding MLVA cluster 1.  
 
3. While three 100% corresponding types could be 
discriminated with the methods used in our study among the 
PCR-based typing techniques, one of these PCR types was 
found two different PFGE types by the year of isolation. 
 
4. The ESBL isolates have been found indistinguishable in 
each of these laboratory tests, one genetic clone has been 
revealed in the background of ESBL cases by PFGE. The 
ESBL positive isolates have been proven to harbour a ~62 
Md plasmid and two class-1 integrons (0.9 kb, 1.875 kb). 
PCR-sequencing has been performed on the ESBL outbreak 
strain and has revealed a blaSHV gene that encodes for an 
SHV-2a. All but one of the further representative isolates of 
the collection belonged to a second PFGE clone. 
 
5. Out of the 85 Enterobacter sp. isolates 41 (48 %) were 
confirmed as ESBL. ESBL strains were seen in an 
increasing number year by year. ESBL E. cloacae isolates 
were more frequent (n=36) than ESBL E. aerogenes strains 
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(n=5). Four small outbreaks affecting two or three patients 
were highlighted by ERIC-PCR; all of them were caused by 
E. cloacae strains. The further 23 cases were found to be 
sporadic as belonged to unique ERIC patterns. Presence and 
expression of SHV-2a ESBL gene was proved by the 
concordant results by MIC testing, IEF, and DNA-
sequencing in the E. cloacae strains of both patients 
involved in the first recorded small outbreak caused by 
ESBL E. cloacae strains in Hungary. The conjugative ESBL 
plasmid harbored an aminoglycoside and a tetracycline 
resistance determinant as well. 
 
6. 44%, 19%, 17%, and 15% of isolates derived from urinary 
tract, bloodstream, respiratory tract, and wound infections, 
respectively. Four ERIC-types (A, B, C, and D) were 
distinguished, but 109 isolates were found to belong to a 
single, epidemic ERIC-type: A. PFGE results suggested the 
monoclonal origin of the epidemic-type-isolates. Forty-two 
patients were involved in four outbreaks caused by the 
epidemic-type-strains. Eighty-one cases were found 
nosocomial. At least fourfold reduction in ciprofloxacin 
MICs was found in the presence of PAβN in 79% of 
representative isolates (representing types A, C, and D); at 
least eightfold reduction in ciprofloxacin MICs in the 
presence of PAβN (PAβN+) was found in 37% of 
representative isolates (types A, and C). Eighty-five 
percents of representative isolates were found to be 
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cyclohexane-tolerant (types A, C, and D). 
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CONCLUSIONS  
 
1. Penicillin susceptibility of respiratory tract isolates is 
suggested to be examined with E-test. Week positive 
correlation between β-lactam and levofloxacin MIC values 
of S. pneumoniae isolates is reported first here. Emergence 
of extremely high penicillin and cefotaxime resistance and 
high level levofloxacin resistance in Hungarian clinical 
isolates of Streptococcus pneumoniae is also reported first 
here. 
 
2. This is the first molecular study on VanB VRE isolates from 
Hungary, and VanA E. faecium isolates from Hungary and 
Serbia. Our results provide further evidence for the special 
clinical importance of CC-17 in hospital outbreaks and 
extend the documented occurrence of the pandemic MLST 
type to a novel region in Europe. 
 
3. Comparing the results by the ERIC-PCR, the DAF-PCR, 
and the PFGE examinations, PFGE was found to be the best 
for hospital epidemiological examinations discriminating 
the outbreak strain from those isolated from the 
environment and the patients cared at the particular unit 
previously, in 2002. Our results showed that the strains 
isolated from patients in 2002 were able to persist in the 
hospital environment for months, as were found in the 
environment in the hospital hygienic screening as well. On 
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the other hand, the strains isolated from the patients affected 
by the small outbreak in 2003 and were found in further two 
patients by the hospital hygienic screening were not found 
in the environment.  By the examination of class-1 integron 
patterns, the isolates from 2002 were also found to be 
different from those from 2003. Comparing the nucleotide 
sequences found in the class-1 integron of the outbreak 
strain to those found in an international database, emergence 
of an epidemic type described previously in another country 
might be assumed in Hungary. The lower discriminatory 
power of the PCR-based techniques found in our study 
might be explained by the emergence of an epidemic type in 
the particular unit. 
 
4. Considering the results by the molecular epidemiological 
examinations, there was a large outbreak, affecting 94 
premature newborn babies, and, with respect to their clinical 
relatedness and our laboratory findings there was a small 
outbreak caused by the ESBL clone. This is the first 
description of SHV-2a positive E. cloacae strains isolated in 
Hungary. 
 
5. More than 2/3 of cases were caused by sporadic strains. 
Only small outbreaks were found. No epidemic clone 
(causing at least two cases at least two times) was found, the  
outbreak clones were found to be ephemeral. The ESBL 
plasmid isolated from the first outbreak strain harbored 
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blaSHV-2a, aac-III/2, and tetA genes. As tetA is widely 
distributed in many species of the Enterobacteriaceae 
family, but unusual in E. cloacae, the presence of tetA in E. 
cloacae on a large conjugative plasmid harboring more 
resistance determinants and so, conferring multi-drug 
resistance suggests the interspecies spread of such plasmids 
in vivo between E. cloacae and other species of the 
Enterobacteriaceae family. 
 
6. This is the first report of wide distribution of cyclohexane-
tolerant or PAβN+ E. cloacae strains. These features, 
indicators of adaptive mechanisms that help bacteria to 
survive in the hospital wards might have contributed to the 
nationwide spread of type-A-strains.  
. 
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